94results about How to "Less variability" patented technology

A printing method includes steps of applying an ink-receptive coating to a substrate; printing an actinic radiation-curable ink jet ink over the coating; and curing the printed ink jet ink. An article printed by the method has a ink-receptive coating layer with a cured print. An apparatus for carrying out the method includes a coating station at which the ink-receptive coating is applied to a substrate, an ink jet printhead at which the energy-curable ink jet ink is applied, and a source of actinic radiation for curing the applied ink. The ink may be applied in sufficient amount to achieve a color density comparable to that obtained using other printing processes such as flexographic or gravure printing processes. The ink-receptive coating layer may be of a thickness sufficient to provide improve surface smoothness and / or reduced drop spread relative to an uncoated substrate.

A light emitting apparatus comprising a light emitting device (101) disposed on a supporting body (105), and coating layers ((108, 109) that bind a fluorescent substance that absorbs light emitted by the light emitting device (101) and emits light of a different wavelength and secures the fluorescent substance onto the surface of the light emitting device (101). The coating layers (108, 109) are made of an inorganic material including an oxide and a hydroxide, each containing at least one element selected from the group consisting of Si, Al, Ga, Ti, Ge, P, B, Zr, Y, Sn, Pb and alkali earth metals. Also an adhesive layer (110) is made of the same inorganic material as that of the coating layers (108, 109).

Active noise reduction headphones for audiometry where the earphone portion of said headphones has a cavity volume greater than 6 cc and including an acoustic-electric sensing means and an electro-acoustic transducing means which are used cooperatively and which has additional passive noise control means in the form of a circumaural seal around the ear for improving high frequency noise control performance, the headphone having a summing junction for combining the active noise reduction signal and an audiometry test signal.

The presently described technology provides compositions comprising aryl carboxylic acids chemically conjugated to hydrocodone (morphinan-6-one, 4,5-alpha-epoxy-3-methoxy-17-methyl) to form novel prodrugs / compositions of hydrocodone, including benzoates and heteroaryl carboxylic acids, which have a decreased potential for abuse of hydrocodone. The present technology also provides methods of treating patients, pharmaceutical kits and methods of synthesizing conjugates of the present technology.

A buried thin film resistor having end caps defined by a dielectric mask is disclosed. A thin film resistor is formed on an integrated circuit substrate. A resistor protect layer is formed over the thin film resistor. First and second portions of a first dielectric material are formed over the resistor protect layer over the first and second ends of the thin film resistor. The resistor protect layer is then wet etched using the first and second portions of the first dielectric material as a hard mask. Then a second dielectric layer is deposited. A first via mask and etch process is used to etch vias down to the underlying portions of the resistor protect layer over the ends of the thin film resistor. A second via mask and etch process is used to etch substrate vias to an underlying conductor layer.

A method for operating a cardiac pacemaker in which the mode of operation of the pacemaker is altered in response to detecting an episode of atrial tachycardia. In accordance with the invention, the pacemaker's pacing mode is altered in a manner that attempts to maintain hemodynamic stability during the atrial tachycardia. Such a mode switch is particularly applicable to pacemaker patients suffering from some degree of congestive heart failure.

A drug in a solubility-improved form is combined with a concentration-enhancing polymer in a sufficient amount so that the combination provides substantially enhanced drug concentration in a use environment relative to a control comprising the same amount of the same solubility-improved form of drug without the concentration-enhancing polymer.

A solubility-improved drug form is combined with a concentration-enhancing polymer in a sufficient amount so that the combination provides substantially enhanced drug concentration in a use environment relative to a control comprising the same amount of the same drug form without the concentration-enhancing polymer.

A method and system for operating a cardiac pacemaker which employs pacing therapy to regularize the ventricular rhythm together with biventricular sensing. Biventricular sensing allows the ventricular rate regularization to be accomplished with greater hemodynamic stability.

An absorbent article for absorbing body fluids and exudates, such as urine and fecal material. More particularly, an absorbent article, such as disposable diapers and adult incontinence garments, which includes an improved waist feature for improved fit and performance.

A system and method for testing lines in a network. The system and method are described in connection with a system for use with a telephone network to aid a network operator determine whether the any line can support high speed data services. According to the method, a mapping is created between low frequency measurements and average loop loss over a high frequency range. The average loop loss is sued to compute the equivalent working length of a line, which is an industry standard measure of the ability of a line to support high speed data services.

A method for operating a cardiac pacemaker in which the mode of operation of the pacemaker is altered in response to detecting an episode of atrial tachycardia. In accordance with the invention, the pacemaker's pacing mode is altered in a manner that attempts to maintain hemodynamic stability during the atrial tachycardia. Such a mode switch is particularly applicable to pacemaker patients suffering from some degree of congestive heart failure.

The present invention provides for simple and streamlined boresight correlation of FLIR-to-missile video. Boresight correlation is performed with un-NUCed missile video, which allows boresight correlation and NUC to be performed simultaneously thereby reducing the time required to acquire a target and fire the missile. The current approach uses the motion of the missile seeker for NUCing to produce spatial gradient filtering in the missile image by differencing images as the seeker moves. This compensates DC non-uniformities in the image. A FLIR image is processed with a matching displace and subtract spatial filter constructed based on the tracked scene motion. The FLIR image is resampled to match the missile image resolution, and the two images are preprocessed and correlated using conventional methods. Improved NUC is provided by cross-referencing multiple measurements of each area of the scene as viewed by different pixels in the imager. This approach is based on the simple yet novel premise that every pixel in the array that looks at the same thing should see the same thing. As a result, the NUC terms adapt to non-uniformities in the imager and not the scene.

A method for operating a cardiac pacemaker in which the mode of operation of the pacemaker is altered in response to detecting an episode of atrial tachycardia. In accordance with the invention, the pacemaker's pacing mode is altered in a manner that attempts to maintain hemodynamic stability during the atrial tachycardia. Such a mode switch is particularly applicable to pacemaker patients suffering from some degree of congestive heart failure.

The present invention relates to prompt-release oral pharmaceutical compositions containing one or more active principles solubilised, suspended or embedded in a suitably formulated amphiphilic matrix for improving in vitro and in vivo bioavailability of medicaments sparingly absorbed through the oral route and / or with problems of high variability of absorption in the gastrointestinal tract.

A ferrite core comprising a sintered oxide containing at least 48.6 to 53.9 mol% of Fe on Fe2O3 basis, 12.3 to 35.2 mol % of Ni on NiO basis and 16.4 to 37.0 mol % of Zn on ZnO basis as metal elements, and contains a crystal phase comprising two or more kinds of solid solutions selected from NiFe2O4, ZnFe2O4 and FeFe2O4, wherein full width at half maximum of a diffraction peak, of crystal phase of which diffraction angle 2θ is in a range from 34.6 to 36.4° as measured by X-ray diffraction analysis using Cu—Kα beam, is 0.4° or less.

A method for operating a cardiac pacemaker in which the mode of operation of the pacemaker is altered in response to detecting an episode of atrial tachycardia. In accordance with the invention, the pacemaker's pacing mode is altered in a manner that attempts to maintain hemodynamic stability during the atrial tachycardia. Such a mode switch is particularly applicable to pacemaker patients suffering from some degree of congestive heart failure.

The present invention relates to an ultrasound transducer assembly (100) comprising ultrasound transducer elements (175, 175a) for transmitting ultrasound waves in a general transmission direction (A). Each of or each of part of the ultrasound transducer elements (175, 175a) comprises a piezoelectric layer (110, 110a) having a top surface, a bottom surface and a side surface with respect to the general transmission direction (A), as well as a bottom electrode layer (111, 111a) and a top electrode layer (112, 112a). A conductive layer (125) is applied at least partly on the side surface of at least one specific one (110a) of the piezoelectric layers, such that the conductive layer (125) is connected to the top electrode layer (112a) and the bottom electrode layer (111a) of said specific piezoelectric layer (110a).

A system and method for moving target based non-uniformity calibration for optical images. The described approach allows for the use of the same test chamber to perform non-uniformity calibration and moving target tests. The current approach works by scanning a test scene having a target and a background at different intensity levels in an overlapping pattern across the imager FOV and cross-referencing multiple measurements of each pixel of a test scene as viewed by different pixels in the imager; each fully-compensated image pixel sees multiple different scene pixels and each scene pixel is seen by multiple imager pixels. For each fully-compensated imager pixel, an Nth order correlation is performed on the measured and estimate pixel response data to calculate the NUC terms. This approach is based on the simple yet novel premise that every fully-compensated pixel in the array that looks at the same thing should see the same thing.

The present invention provides for simple and streamlined boresight correlation of FLIR-to-missile video. Boresight correlation is performed with un-NUCed missile video, which allows boresight correlation and NUC to be performed simultaneously thereby reducing the time required to acquire a target and fire the missile. The current approach uses the motion of the missile seeker for NUCing to produce spatial gradient filtering in the missile image by differencing images as the seeker moves. This compensates DC non-uniformities in the image. A FLIR image is processed with a matching displace and subtract spatial filter constructed based on the tracked scene motion. The FLIR image is resampled to match the missile image resolution, and the two images are preprocessed and correlated using conventional methods. Improved NUC is provided by cross-referencing multiple measurements of each area of the scene as viewed by different pixels in the imager. This approach is based on the simple yet novel premise that every pixel in the array that looks at the same thing should see the same thing. As a result, the NUC terms adapt to non-uniformities in the imager and not the scene.

Disclosed are product (e.g., panels), slurry, and methods relating to an uncooked starch having a mid-range peak viscosity (i.e., from about 120 Brabender Units to about 900 Brabender Units).

The presently described technology provides compositions comprising aryl carboxylic acids and, for example NSAIDs, chemically conjugated to oxycodone (4,5-α-epoxy-14-hydroxy-17-methylmorphinan-6-one) to form novel prodrugs / compositions of oxycodone, including benzoates, salicylates, propionates, fenamates, and acetates, which have a decreased potential for abuse of oxycodone. The present technology also provides methods of treating patients, pharmaceutical kits and methods of synthesizing conjugates of the present technology.